Kyverna Therapeutics, Inc.KYTXNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-127.48M
↓ 110% below average
Average (3y)
$-60.77M
Historical baseline
Range
High:$-26.35M
Low:$-127.48M
CAGR
+69.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-127.48M | -111.2% |
| 2023 | $-60.37M | -108.9% |
| 2022 | $-28.89M | -9.7% |
| 2021 | $-26.35M | - |